Dendrimers as vectors for genetic material delivery to the nervous system

Current Medicinal Chemistry

Volumn 19, Issue 29, 2012, Pages 5101-5108

  Perez Martinez F C ^c   Ocana A V ^a,b   Perez Carrion M D ^c   Cena V ^a,b,c  

^a UNIVERSITY OF CASTILLA LA MANCHA   (Spain)

^b INSTITUTO DE SALUD CARLOS III   (Spain)

^c Campus Universitario   (Spain)

Author keywords

Blood brain barrier; Dendrimers; DNA; Glioblastoma; Neurons; SiRNA; Transfection

Indexed keywords

DENDRIMER; DNA; HIGH MOBILITY GROUP B1 PROTEIN; PENTETIC ACID; PHOSPHOROUS ACID; POLYAMIDOAMINE; SMALL INTERFERING RNA; TRANSFERRIN;

BLOOD BRAIN BARRIER; CELL MEMBRANE; CENTRAL NERVOUS SYSTEM; CYTOTOXICITY; DNA TRANSFECTION; GENE TARGETING; GENE THERAPY; GLIA CELL; GLIOBLASTOMA; IN VITRO STUDY; IN VIVO STUDY; NERVE CELL; NEUROTOXICITY; PARTICLE SIZE; REVIEW;

ANIMALS; BLOOD-BRAIN BARRIER; DENDRIMERS; DRUG CARRIERS; GENE TRANSFER TECHNIQUES; GENETIC VECTORS; HUMANS; TRANSFECTION;

EID: 84870429669     PISSN: 09298673     EISSN: 1875533X     Source Type: Journal    
DOI: 10.2174/0929867311209025101     Document Type: Review

References (60)

1. Pérez-Martínez, F. C.; Guerra, J.; Posadas, I.; Ceña, V. Barriers to Non-Viral Vector-Mediated Gene Delivery in the Nervous System. Pharm. Res., 2011, 28(8), 1843-1858
2. Caminade, A. M.; Turrin, C. O.; Majoral, J. P. Dendrimers and DNA: combinations of two special topologies for nanomaterials and biology. Chemistry., 2008, 14 (25), 7422-7432.
3. Posadas, I.; Guerra, F. J.; Ceña, V. Nonviral vectors for the delivery of small interfering RNAs to the CNS. Nanomedicine, (Lond) 2010, 5 (8), 1219-1236.
4. Fernández, M.; Segura, M. F.; Sole, C.; Colino, A.; Comella, J. X.; Ceña, V. Lifeguard/neuronal membrane protein 35 regulates Fas ligand-mediated apoptosis in neurons via microdomain recruitment. J. Neurochem., 2007, 103 (1), 190-203.
5. Guerra-Crespo, M.; Charli, J. L.; Rosales-Garcia, V. H.; Pedraza-Alva, G.; Pérez-Martínez, L. Polyethylenimine improves the transfection efficiency of primary cultures of post-mitotic rat fetal hypothalamic neurons. J. Neurosci. Methods, 2003, 127 (2), 179-192.
6. Dalby, B.; Cates, S.; Harris, A.; Ohki, E. C.; Tilkins, M. L.; Price, P. J.; Ciccarone, V. C. Advanced transfection with Lipofectamine 2000 reagent: primary neurons, siRNA, and high-throughput applications. Methods, 2004, 33 (2), 95-103.
7. Bergen, J. M.; Park, I. K.; Horner, P. J.; Pun, S. H. Nonviral approaches for neuronal delivery of nucleic acids. Pharm. Res., 2008, 25 (5), 983-998.
8. Hourani, R.; Kakkar, A. Advances in the Elegance of Chemistry in Designing Dendrimers. Macromolecular Rapid Comm., 2010, 31 (11), 947-974.
9. Lee, C. C.; MacKay, J. A.; Frechet, J. M.; Szoka, F. C. Designing dendrimers for biological applications. Nat. Biotechnol., 2005, 23 (12), 1517-1526.
10. Dutta, T.; Garg, M.; Jain, N. K. Targeting of efavirenz loaded tuftsin conjugated poly(propyleneimine) dendrimers to HIV infected macrophages in vitro. Eur. J. Pharm. Sci., 2008, 34 (2-3), 181-189.
11. Wolinsky, J. B.; Grinstaff, M. W. Therapeutic and diagnostic applications of dendrimers for cancer treatment. Advanced Drug Delivery Reviews, 2008, 60 (9), 1037-1055.
12. Menjoge, A. R.; Kannan, R. M.; Tomalia, D. A. Dendrimer-based drug and imaging conjugates: design considerations for nanomedical applications. Drug Discov. Today, 2010, 15 (5GÇô6), 171-185.
13. Albertazzi, L.; Brondi, M.; Pavan, G. M.; Sato, S. S.; Signore, G.; Storti, B.; Ratto, G. M.; Beltram, F. Dendrimer-based fluorescent indicators: in vitro and in vivo applications. PLoSONE, 2011, 6 (12), e28450.
14. Tang, M. X.; Redemann, C. T.; Szoka, F. C., Jr. In vitro gene delivery by degraded polyamidoamine dendrimers. Bioconjug. Chem., 1996, 7 (6), 703-714.
15. Esfand, R.; Tomalia, D. A. Poly(amidoamine) (PAMAM) dendrimers: from biomimicry to drug delivery and biomedical applications. Drug Discov. Today, 2001, 6 (8), 427-436.
16. Braun, C. S.; Vetro, J. A.; Tomalia, D. A.; Koe, G. S.; Koe, J. G.; Middaugh, C. R. Structure/function relationships of polyamidoamine/DNA dendrimers as gene delivery vehicles. J. Pharm. Sci., 2005, 94 (2), 423-436.
17. Kobayashi, H.; Brechbiel, M. W. Nano-sized MRI contrast agents with dendrimer cores. Adv. Drug Deliv. Rev., 2005, 57 (15), 2271-2286.
18. Choi, H. S.; Liu, W.; Misra, P.; Tanaka, E.; Zimmer, J. P.; Itty, I. B.; Bawendi, M. G.; Frangioni, J. V. Renal clearance of quantum dots. Nat. Biotechnol., 2007, 25 (10), 1165-1170.
19. Sarin, H.; Kanevsky, A. S.; Wu, H.; Brimacombe, K. R.; Fung, S. H.; Sousa, A. A.; Auh, S.; Wilson, C. M.; Sharma, K.; Aronova, M. A.; Leapman, R. D.; Griffiths, G. L.; Hall, M. D. Effective transvascular delivery of nanoparticles across the blood-brain tumor barrier into malignant glioma cells. J. Transl. Med., 2008, 6, 80.
20. Posadas, I.; Lopez-Hernandez, B.; Clemente, M. I.; Jimenez, J. L.; Ortega, P.; de la, M. J.; Gomez, R.; Munoz-Fernandez, M. A.; Ceña, V. Highly efficient transfection of rat cortical neurons using carbosilane dendrimers unveils a neuroprotective role for HIF-1alpha in early chemical hypoxiamediated neurotoxicity. Pharm. Res., 2009, 26 (5), 1181-1191.
21. Kim, T. I.; Bai, C. Z.; Nam, K.; Park, J. S. Comparison between arginine conjugated PAMAM dendrimers with structural diversity for gene delivery systems. J. Control. Release, 2009, 136 (2), 132-139.
22. Rodrigo, A. C.; Rivilla, I.; Pérez-Martínez, F. C.; Monteagudo, S.; Ocaña, V.; Guerra, J.; García-Martínez, J. C.; Merino, S.; Sánchez-Verdú, P.; Ceña, V.; Rodríguez-López, J. Efficient, Non-Toxic Hybrid PPV-PAMAM Dendrimer as a Gene Carrier for Neuronal Cells. Biomacromolecules, 2011, 12 (4), 1205-1213.
23. Ohki, E. C.; Tilkins, M. L.; Ciccarone, V. C.; Price, P. J. Improving the transfection efficiency of post-mitotic neurons. J. Neurosci. Methods, 2001, 112 (2), 95-99.
24. Kim, I. D.; Lim, C. M.; Kim, J. B.; Nam, H. Y.; Nam, K.; Kim, S. W.; Park, J. S.; Lee, J. K. Neuroprotection by biodegradable PAMAM ester (e-PAMR)-mediated HMGB1 siRNA delivery in primary cortical cultures and in the postischemic brain. J. Control. Release, 2010, 142 (3), 422-430.
25. Jimenez, J. L.; Clemente, M. I.; Weber, N. D.; Sánchez, J.; Ortega, P.; de la Mata, F. J.; Gómez, R.; García, D.; López-Fernández, L. A.; Muñoz-Fernández, M. A. Carbosilane dendrimers to transfect human astrocytes with small interfering RNA targeting human immunodeficiency virus. BioDrug, 2010, 24 (5), 331-343.
26. Pérez-Carrión, M. D.; Pérez-Martínez, F. C.; Merino, S.; Sánchez-Verdú, P.; Martinez-Hernández, J.; Luján, R.; Ceña, V. Dendrimer-mediated siRNA delivery knocks down Beclin 1 and potentiates NMDA-mediated toxicity in rat cortical neurons. J. Neurochem., 2011. 120 (2), 259-268.
27. Posadas, I.; Pérez-Martínez, F. C.; Guerra, J.; Sánchez-Verdú, P.; Ceña, V. Cofilin activation mediates Bax translocation to mitochondria during excitotoxic neuronal death. J. Neurochem., 2012, 120 (4), 515-527.
28. Waite, C. L.; Sparks, S. M.; Uhrich, K. E.; Roth, C. M. Acetylation of PAMAM dendrimers for cellular delivery of siRNA. BMC. Biotechnol., 2009, 9, 38.
29. Patel, D.; Henry, J.; Good, T. Attenuation of beta-amyloid induced toxicity by sialic acid-conjugated dendrimeric polymers. Biochim. Biophys. Acta, 2006, 1760 (12), 1802-1809.
30. Wasiak, T.; Ionov, M.; Nieznanski, K.; Nieznanska, H.; Klementieva, O.; Granell, M.; Cladera, J.; Majoral, J. P.; Caminade, A. M.; Klajnert, B. Phosphorus Dendrimers Affect Alzheimer's (Abeta(1-28)) Peptide and MAPTau Protein Aggregation. Mol. Pharm., 2012. 9(3), 458-469.
31. Yang, H. Nanoparticle-mediated brain-specific drug delivery, imaging, and diagnosis. Pharm. Res., 2010, 27 (9), 1759-1771.
32. Adamson, R. H.; Lenz, J. F.; Zhang, X.; Adamson, G. N.; Weinbaum, S.; Curry, F. E. Oncotic pressures opposing filtration across non-fenestrated rat microvessels. J. Physiol., 2004, 557 (Pt 3), 889-907.
33. Ke, W.; Shao, K.; Huang, R.; Han, L.; Liu, Y.; Li, J.; Kuang, Y.; Ye, L.; Lou, J.; Jiang, C. Gene delivery targeted to the brain using an Angiopepconjugated polyethyleneglycol-modified polyamidoamine dendrimer. Biomaterials, 2009, 30 (36), 6976-6985.
34. Lockman, P. R.; Oyewumi, M. O.; Koziara, J. M.; Roder, K. E.; Mumper, R. J.; Allen, D. D. Brain uptake of thiamine-coated nanoparticles. J Control. Release, 2003, 93 (3), 271-282.
35. Huang, R.; Ke, W.; Han, L.; Liu, Y.; Shao, K.; Jiang, C.; Pei, Y. Lactoferrinmodified nanoparticles could mediate efficient gene delivery to the brain in vivo. Brain Res. Bull., 2010, 81 (6), 600-604.
36. Dhanikula, R. S.; Argaw, A.; Bouchard, J. F.; Hildgen, P. Methotrexate Loaded Polyether-Copolyester Dendrimers for the Treatment of Gliomas: Enhanced Efficacy and Intratumoral Transport Capability. Mol. Pharm., 2008, 5(1), 105-116.
37. Huang, R. Q.; Qu, Y. H.; Ke, W. L.; Zhu, J. H.; Pei, Y. Y.; Jiang, C. Efficient gene delivery targeted to the brain using a transferrin-conjugated polyethyleneglycol-modified polyamidoamine dendrimer. FASEB J., 2007, 21 (4), 1117-1125.
38. Lee, H. J.; Engelhardt, B.; Lesley, J.; Bickel, U.; Pardridge, W. M. Targeting rat anti-mouse transferrin receptor monoclonal antibodies through bloodbrain barrier in mouse. J. Pharmacol. Exp. Ther., 2000, 292 (3), 1048-1052.
39. Huang, R.; Ke, W.; Liu, Y.; Wu, D.; Feng, L.; Jiang, C.; Pei, Y. Gene therapy using lactoferrin-modified nanoparticles in a rotenone-induced chronic Parkinson model. J. Neurol. Sci., 2010, 290 (1-2), 123-130.
40. Lafon, M. Rabies virus receptors. J. Neurovirol., 2005, 11 (1), 82-87.
41. Liu, Y.; Huang, R.; Han, L.; Ke, W.; Shao, K.; Ye, L.; Lou, J.; Jiang, C. Brain-targeting gene delivery and cellular internalization mechanisms for modified rabies virus glycoprotein RVG29 nanoparticles. Biomaterials, 2009, 30 (25), 4195-4202.
42. Agrawal, A.; Min, D. H.; Singh, N.; Zhu, H.; Birjiniuk, A.; von, M. G.; Harris, T. J.; Xing, D.; Woolfenden, S. D.; Sharp, P. A.; Charest, A.; Bhatia, S. Functional delivery of siRNA in mice using dendriworms. ACS Nano., 2009, 3 (9), 2495-2504.
43. Navarro, G.; Maiwald, G.; Haase, R.; Rogach, A. L.; Wagner, E.; de Ilarduya, C. T.; Ogris, M. Low generation PAMAM dendrimer and CpG free plasmids allow targeted and extended transgene expression in tumors after systemic delivery. J. Control. Release, 2010, 146 (1), 99-105.
44. Herweijer, H.; Zhang, G.; Subbotin, V. M.; Budker, V.; Williams, P.; Wolff, J. A. Time course of gene expression after plasmid DNA gene transfer to the liver. J. Gene Med., 2001, 3 (3), 280-291.
45. Hyde, S. C.; Pringle, I. A.; Abdullah, S.; Lawton, A. E.; Davies, L. A.; Varathalingam, A.; Nunez-Alonso, G.; Green, A. M.; Bazzani, R. P.; Sumner-Jones, S. G.; Chan, M.; Li, H.; Yew, N. S.; Cheng, S. H.; Boyd, A. C.; Davies, J. C.; Griesenbach, U.; Porteous, D. J.; Sheppard, D. N.; Munkonge, F. M.; Alton, E. W.; Gill, D. R. CpG-free plasmids confer reduced inflammation and sustained pulmonary gene expression. Nat. Biotechnol., 2008, 26 (5), 549-551.
46. Furnari, F. B.; Fenton, T.; Bachoo, R. M.; Mukasa, A.; Stommel, J. M.; Stegh, A.; Hahn, W. C.; Ligon, K. L.; Louis, D. N.; Brennan, C.; Chin, L.; DePinho, R. A.; Cavenee, W. K. Malignant astrocytic glioma: genetics, biology, and paths to treatment. Genes Dev., 2007, 21 (21), 2683-2710.
47. Stupp, R.; Hottinger, A. F.; van den Bent, M. J.; Dietrich, P. Y.; Brandes, A. A. Frequently asked questions in the medical management of high-grade glioma: a short guide with practical answers. Ann. Oncol., 2008, 19 Suppl 7, vii209-vii216.
48. Stupp, R.; Mason, W. P.; van den Bent, M. J.; Weller, M.; Fisher, B.; Taphoorn, M. J.; Belanger, K.; Brandes, A. A.; Marosi, C.; Bogdahn, U.; Curschmann, J.; Janzer, R. C.; Ludwin, S. K.; Gorlia, T.; Allgeier, A.; Lacombe, D.; Cairncross, J. G.; Eisenhauer, E.; Mirimanoff, R. O. Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma. N. Engl. J. Med., 2005, 352 (10), 987-996.
49. Wells, A. EGF receptor. Int. J. Biochem. Cell Biol., 1999, 31 (6), 637-643.
50. Engelman, J. A.; Luo, J.; Cantley, L. C. The evolution of phosphatidylinositol 3-kinases as regulators of growth and metabolism. Nat. Rev. Genet., 2006, 7 (8), 606-619.
51. Easton, J. B.; Houghton, P. J. mTOR and cancer therapy. Oncogene, 2006, 25 (48), 6436-6446.
52. Cai, W.; Chen, X. Anti-angiogenic cancer therapy based on integrinalphavbeta3 antagonism. Anticancer Agents Med. Chem., 2006, 6 (5), 407-428.
53. Waite, C. L.; Roth, C. M. PAMAM-RGD conjugates enhance siRNA delivery through a multicellular spheroid model of malignant glioma. Bioconjug. Chem., 2009, 20 (10), 1908-1916.
54. Yang, W.; Barth, R. F.; Wu, G.; Huo, T.; Tjarks, W.; Ciesielski, M.; Fenstermaker, R. A.; Ross, B. D.; Wikstrand, C. J.; Riley, K. J.; Binns, P. J. Convection enhanced delivery of boronated EGF as a molecular targeting agent for neutron capture therapy of brain tumors. J. Neurooncol., 2009, 95 (3), 355-365.
55. Wu, G.; Barth, R. F.; Yang, W.; Kawabata, S.; Zhang, L.; Green-Church, K. Targeted delivery of methotrexate to epidermal growth factor receptorpositive brain tumors by means of cetuximab (IMC-C225) dendrimer bioconjugates. Mol. Cancer Ther., 2006, 5 (1), 52-59.
56. Kaneshiro, T. L.; Lu, Z. R. Targeted intracellular codelivery of chemotherapeutics and nucleic acid with a well-defined dendrimer-based nanoglobular carrier. Biomaterials, 2009, 30 (29), 5660-5666.
57. Rittierodt, M.; Harada, K. Repetitive doxorubicin treatment of glioblastoma enhances the PGP expression-a special role for endothelial cells. Exp. Toxicol. Pathol., 2003, 55 (1), 39-44.
58. Han, L.; Zhang, A.; Wang, H.; Pu, P.; Jiang, X.; Kang, C.; Chang, J. Tat-BMPs-PAMAM conjugates enhance therapeutic effect of small interference RNA on U251 glioma cells in vitro and in vivo. Hum. Gene Ther., 2010, 21 (4), 417-426.
59. Hobbs, S. K.; Monsky, W. L.; Yuan, F.; Roberts, W. G.; Griffith, L.; Torchilin, V. P.; Jain, R. K. Regulation of transport pathways in tumor vessels: role of tumor type and microenvironment. Proc. Natl. Acad. Sci. U. S. A., 1998, 95 (8), 4607-4612.
60. Sarin, H.; Kanevsky, A. S.; Wu, H.; Sousa, A. A.; Wilson, C. M.; Aronova, M. A.; Griffiths, G. L.; Leapman, R. D.; Vo, H. Q. Physiologic upper limit of pore size in the blood-tumor barrier of malignant solid tumors. J. Transl. Med., 2009, 7, 51-60.